News for ImmuPharma plc (IMMPF)

The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- Challenger Energy Group PLC - ...

Major shareholding by Lanstead via TR1 14th September 2023 - 12:42 pm To view notification form click here Attachments Original Link ...

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting,... | May 18, 2023

FDA confirms Type-C meeting date of 7th June 2023 for Phase 2/3 adaptive study of Lupuzor™ in lupus 20th April 2023 - 10:20 am ImmuPharma PLC , the specialist drug... | April 20, 2023

The following stocks are the leading risers and fallers on AIM in London on Wednesday. ---------- AIM - WINNERS ---------- System1 Group PLC, up 17% at 189.5 pence, 12-month range 115p-295p. The... | April 12, 2023

ImmuPharma PLC on Monday confirmed alongside its partner Avion Pharmaceuticals that a phase 2/3 adaptive trial will be the best design for the next clinical study of Lupuzor in systemic lupus... | February 6, 2023

Avion confirms its continued support to the Lupuzor™ clinical program in Lupus whilst exploring broader collaboration opportunities 18th November 2022 - 12:04 pm ... | November 18, 2022

The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: ---------- Synectics PLC - Sheffield, England-based security systems... | November 11, 2022

Read ImmuPharma (LON:IMM) Stock Price Passes Below Two Hundred Day Moving Average of $5.74 at ETF Daily News